Learn More
Selleck Chemical LLC LQZ-7I-E0108-25MG

Supplier: Selleck Chemical LLC E010825MG

LQZ-7I is a novel selectively inhibitor of survivin dimerization with IC50s of 4 8 M and 3 1 M in prostate cancer cell lines PC-3 and C4-2 respectively LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.